☆ 4.7 Article

Detection of circulating cell-free HPV DNA of 13 HPV types for patients with cervical cancer as potential biomarker to monitor therapy response and to detect relapse

BRITISH JOURNAL OF CANCER (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Oncology

Circulating cell-free tumor human papillomavirus DNA is a promising biomarker in cervical cancer

Lars Sivars et al.

Summary: This study aimed to analyze the detectability of cell-free human papillomavirus DNA (ctHPV DNA) in patients with cervical cancer or pre-malignant lesions and its correlation with patient and tumor characteristics and outcome. The results showed a high proportion of ctHPV DNA detection in patients with locally advanced cervical cancer, and its levels were correlated with disease staging. Furthermore, the presence of ctHPV DNA was associated with worse progression-free survival in patients.

GYNECOLOGIC ONCOLOGY (2022)

添加到收藏夹

Meeting Abstract Oncology

CIRCULATING HPV CELL-FREE DNA IN CERVICAL CANCER

Suzana Mittelstadt et al.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2022)

添加到收藏夹

Article Medicine, Research & Experimental

Rapid and ultrasensitive detection of circulating human papillomavirus E7 cell-free DNA as a cervical cancer biomarker

Phetploy Rungkamoltip et al.

Summary: The study suggests that HPV E7 cfDNA could serve as a specific biomarker for cervical cancer detection with potential for monitoring. Both isothermal detection and ddPCR showed high sensitivity and specificity for HPV16/18 E7 cfDNA, while the RPA-LF method offers an affordable, rapid, and ultrasensitive tool for detecting HPV in resource-limited settings.

EXPERIMENTAL BIOLOGY AND MEDICINE (2021)

添加到收藏夹

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

添加到收藏夹

Review Oncology

cfDNA detection for HPV plus squamous cell carcinomas

Kate Chatfield-Reed et al.

Summary: High-risk HPV is a factor in various squamous cell carcinomas and its cfDNA levels can be indicative of poor prognosis and treatment relapse. Longitudinal sampling has shown that persistent or increasing HPV cfDNA levels can predict treatment failures. Using a liquid biopsy platform for HPV cfDNA may have clinical utility in HPV+ cancer patients.

ORAL ONCOLOGY (2021)

添加到收藏夹

Article Oncology

Targeting extracellular and juxtamembrane FGFR2 mutations in chemotherapy-refractory cholangiocarcinoma

Michael Bitzer et al.

Summary: In this study, two iCCA patients with extracellular and juxtamembrane FGFR2 mutations were treated with an FGFR-inhibiting tyrosine kinase inhibitor under the guidance of MTB, leading to rapid and prolonged partial response. This suggests the importance of predicting the functional consequences of FGFR2 mutations for guiding treatment decisions in iCCA patients.

NPJ PRECISION ONCOLOGY (2021)

添加到收藏夹

Article Oncology

Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA

M. C. Liu et al.

ANNALS OF ONCOLOGY (2020)

添加到收藏夹

Article Oncology

Deep sequencing detects human papillomavirus (HPV) in cervical cancers negative for HPV by PCR

Laila Sara Arroyo Muhr et al.

BRITISH JOURNAL OF CANCER (2020)

添加到收藏夹

Article Oncology

Dynamics of cell-free tumour DNA correlate with treatment response of head and neck cancer patients receiving radiochemotherapy

Franz J. Hilke et al.

RADIOTHERAPY AND ONCOLOGY (2020)

添加到收藏夹

Article Pathology

Plasma Cell-Free Human Papillomavirus Oncogene E6 and E7 DNA Predicts Outcome in Oropharyngeal Squamous Cell Carcinoma

Henrike Reder et al.

JOURNAL OF MOLECULAR DIAGNOSTICS (2020)

添加到收藏夹

Article Oncology

Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer

Bhishamjit S. Chera et al.

CLINICAL CANCER RESEARCH (2019)

添加到收藏夹

Article Virology

Liquid biopsy of HPV DNA in cervical cancer

Tak Hong Cheung et al.

JOURNAL OF CLINICAL VIROLOGY (2019)

添加到收藏夹

Review Genetics & Heredity

Current and future perspectives of liquid biopsies in genomics-driven oncology

Ellen Heitzer et al.

NATURE REVIEWS GENETICS (2019)

添加到收藏夹

Article Oncology

The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology guidelines for the management of patients with cervical cancer

David Cibula et al.

RADIOTHERAPY AND ONCOLOGY (2018)

添加到收藏夹

Article Obstetrics & Gynecology

Cancer of the cervix uteri

Neerja Bhatla et al.

INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2018)

添加到收藏夹

Article Oncology

Circulating Cell-free DNA for Metastatic Cervical Cancer Detection, Genotyping, and Monitoring

Zhigang Kang et al.

CLINICAL CANCER RESEARCH (2017)

添加到收藏夹

Article Oncology

Predicting response to radical (chemo) radiotherapy with circulating HPV DNA in locally advanced head and neck squamous carcinoma

Jen Y. Lee et al.

BRITISH JOURNAL OF CANCER (2017)

添加到收藏夹

Article Oncology

Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

C. Marth et al.

ANNALS OF ONCOLOGY (2017)

添加到收藏夹

Article Oncology

Human Papillomavirus DNA in Plasma of Patients with HPV16 DNA-positive Uterine Cervical Cancer

Takako Shimada et al.

JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2010)

添加到收藏夹

Review Oncology

Human papillomavirus oncoproteins: pathways to transformation

Cary A. Moody et al.

NATURE REVIEWS CANCER (2010)

添加到收藏夹

Article Oncology

Low incidence of HPV DNA in sera of pretreatment cervical cancer patients

VWS Liu et al.

GYNECOLOGIC ONCOLOGY (2001)

添加到收藏夹

Article Oncology

The role of human papillomavirus in cervical adenocarcinoma carcinogenesis

S Andersson et al.

EUROPEAN JOURNAL OF CANCER (2001)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.